CSI Market
Sign In | Register

Usana Health Sciences Inc (USNA) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access USNA quarterly Cash Flow →
The table below presents a historical view of Usana Health Sciences Inc's cash flow activity, supporting analysis of liquidity trends over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Jan 03 2026)
12 Months 		(Dec 28 2024) (Dec 31 2022) (Jan 02 2021) (Dec 28 2019)
Operating Activities
Income11.48
Depreciation & amortization32.56
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Other Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase-32.01
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment-2.09
Share-based Compensation13.83
Income (Loss) from Equity Method Investments0.00
Fair Value of Assets Acquired0.00
Share Based Compensation Arrangements Tax Benefit-
Operating Lease Right Of Use Asset Amortization Expense7.14
Income taxes-7.13
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.00
Increase (Decrease) in Accounts Payable5.20
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.62
Other Working Capital-14.22
Other Noncash Expense0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities6.97
Discontinued operations0.00
Net Cash flow from Operating Activities22.35
Investing Activities
Capital Expenditures-13.82
Sale of Capital Items3.91
Proceeds from Maturities, Prepayments and Calls of Held-to-maturity Securities0.00
Payments to Acquire Trading Securities Held-for-investment0.00
Payments for Hedge, Investing Activities-1.07
Proceeds From Acquisition Of Business Working Capital Adjustments Proceeds From Acquisition Working Capital Adjustment0.87
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Proceeds from Previous Acquisition0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Proceeds from Collection of Notes Receivable0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-10.13
Financing Activities
Short-term debt Net-9.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-27.51
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock-1.75
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-348.10
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents161.24
Disgorgement Of Short Swing Profits By Shareholder-
Proceeds From Disgorgement Of Shortswing Stock Profits-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations184.51
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-40.60
Effect of exchange rate on cash flow5.11
Discontinued operations0.00
Free Cash Flow12.43
Total Cash Flow-23.27
4 historic quarters locked

Sign in to unlock the full Usana Health Sciences Inc cash flow history.

Sign In Create Free Account

About Usana Health Sciences Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000896264-26-000021

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License